Showing papers in "Value in Health in 2003"

TL;DR: It is the responsibility of model developers to conduct modeling studies according to the best practicable standards of quality and to communicate results with adequate disclosure of assumptions and with the caveat that conclusions are conditional upon the assumptions and data on which the model is built.

TL;DR: The February 16, 2001, meeting represented an important step in harmonizing efforts across various organizations and in opening a dialogue with the FDA around major issues related to methodologic standards for measuring and interpreting PROs in the drug evaluation process.

TL;DR: A checklist was developed that focuses on issues that are unique to database studies or are particularly problematic in database research, and could potentially be used to assess retrospective studies that employ other types of databases, such as disease registries and national survey data.

TL;DR: Medication compliance data supported the internal validity of the trial by demonstrating that good compliers had better outcomes, irrespective of treatment with NTX or placebo, and the MEMS feedback methodology is feasible for use in multicenter trials.

TL;DR: There are major differences between men and women in the prevalence and severity of self-reported pain in the population, presumably gender disparities in work, economy, daily living, social life and expectations between women and men.

TL;DR: US cost estimates of the long-term complications of a primary deep vein thrombosis (DVT), including the post-thrombotic syndrome (PTS) and recurrent venous thromboembolism (VTE), are provided.

TL;DR: Compliant with drug therapies for osteoporosis over 1 year is poor leaving patients at risk for fractures and higher health care costs and the effectiveness of both raloxifene and bisphosphonate medications relative to estrogen-only improved significantly with the age of the patient.

TL;DR: The Task Force's additional reporting requirements may be helpful to decision makers, but they raise a number of issues that include the feasibility of meeting the additional requirements, whether decision makers should receive more education in economic evaluation, and whether there should be more study of health-care decision-making procedures themselves.

TL;DR: The economic attractiveness of expanded investment in influenza vaccination hinges on employer- and population-specific assumptions and a simple framework within which competing considerations of disease epidemiology, worker productivity, and economic cost may be weighed is provided.

TL;DR: There are large potential cost offsets both in the health-care sector and in the social service sector if the incidence of first-ever stroke could be reduced.

TL;DR: Patient-generated outcome measures appear to be useful primarily in complementing traditional HRQoL measures, guiding individual patient treatment decisions, and assisting the design of new measures.

TL;DR: SAC is a costly, highly prevalent, chronic condition associated with significant reductions in both ocular and general quality of life, as well as ongoing out-of-pocket expenses and health care costs, and medications that reduce this demand on health care systems and out of pocket expenses by patients could be of potential importance.

TL;DR: The results suggest that for average-risk knee OA patients, acetaminophen dominates the other therapies in terms of cost per GI event averted and cost-effectiveness acceptability curves indicate that if one values pain relief below 275 US dollars per patient achieving MPCI,acetaminophen is the therapy most likely to be optimal.

TL;DR: The EQ-5D is a valid and responsive measure that can be used to generate preference-based valuations of HRQoL in patients with IBS and useful for comparisons in clinical and cost-effectiveness studies.

TL;DR: In this article, the authors compared claims for treatment and costs of fibromyalgia plus depression with those for FM or depression alone, and found that the incremental costs for patients with FM plus depression were more than additive of costs for each condition alone.

TL;DR: The PQAQ is a comprehensive instrument demonstrating face and content validity and strong interrater and test-retest reliability in the appraisal of pediatric economic evaluations and will be valuable to health economists, methods researchers, and policy decision makers involved in allocation decisions for pediatric health care.

TL;DR: A disease-modeling approach generates detailed information on the current and future cost burden of osteoporosis for an individual state population and predictions based on this methodology may enable health-policy decisions that are tailored to local needs.

TL;DR: This supplement engages some of the leading health economists in Europe to analyze how the policies in their respective health-care systems to control and influence pharmaceutical spending are likely to influence the overall performance of their systems, with respect to both cost control and the production of population health.

TL;DR: Oseltamivir for treatment of patients with ILI is potentially cost-effective if clinical diagnostic specificity for influenza observed in clinical trials is applicable to routine practice.

TL;DR: The economic burden on families and society appears heavier for infants born at 33 to 35 weeks of gestation than for full-term infants, including the value of lost productivity but excluding inpatient hospital and physician bills and lost income.

TL;DR: The AMCP and the FMCP believe that the AMCP Format is a tool that will help health systems establish a record of commitment to rational decision making, thus gaining the confidence of patients, clinicians, and members.

TL;DR: The results of EVITA provide a reliable tool for informed decision making and should enhance the acceptance of such models, and results on age shifts and elimination show face validity.

TL;DR: The market share of new medications to treat alcoholism among addiction specialists could surpass the low usage rates of existing medications if those medications have better attributes, however, prescription levels may not reach that expected for treatment of other diseases.

TL;DR: Mini-AQLQ is better on feasibility making it a more efficient way to assess quality of life in adults with mild to moderate asthma, and the three questionnaires are reliable, valid and sensitive to changes.

TL;DR: It was found that management of low-risk FN in a home-care-based setting was associated with significantly lower median total charges with no differences in outcome.

TL;DR: Routine administration of proton pump inhibitors intravenously to all persons presenting with UGI bleeding represents good value for money and merits consideration as standard hospital policy.

TL;DR: Because of its high prevalence, asthma has a high impact on public health and this impact depends on disease severity and, according to these findings, may also depend on the extent to which exacerbations are avoided or at least controlled.